Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Kristina Danga"'
Autor:
Jochen H. Lorch, Christopher A. French, Jonathan D. Schoenfeld, Gerard M. Doherty, Justine A. Barletta, Jeffrey Swanson, Kristina Danga, Matthew A. Nehs, Kristine S. Wong, Raphael Bueno, Alarice C. Lowe, Francis D. Moore, Lindsay E. Kuo, Abby White
Publikováno v:
Clinical Thyroidology. 33:38-47
Autor:
Laurie LeBrun, Kristina Danga, Michelle Slade, Jinyi Zhu, Joel W Thompson, Gang Lu, Xinde Zheng, Mary E Matyskiela, Philip P Chamberlain, Hon Kit Wong, Mark Labow, Thomas Clayton, Joshua M. Baughman
Publikováno v:
ACS chemical biology. 15(12)
There is a growing interest in using targeted protein degradation as a therapeutic modality in view of its potential to expand the druggable proteome. One avenue to using this modality is via molecular glue based Cereblon E3 Ligase Modulating Drug co
Autor:
Steven G. DuBois, Jeanenne J. Nelson, Kristina Danga, Christopher A. French, Arindam Dhar, Robert I. Haddad, Nicole G. Chau, Clement Ma, Stephen E. Sallan, Geoffrey I. Shapiro, Valentina Nardi, Ryan Barrette, Hasan Al-Sayegh, Christopher S. Lathan
Publikováno v:
JNCI Cancer Spectrum
BackgroundNUT midline carcinoma, renamed NUT carcinoma (NC), is an aggressive squamous cancer defined by rearrangement of the NUTM1 gene. Although a subset of patients can be cured, for the majority of patients the prognosis is grim. We sought to cla
Autor:
Christopher A. French, Ivona Filic, Kristina Danga, Chevaun Morrison-Smith, Michael J. Cameron, Tatiana M. Knox, Erica M. Walsh, Amy DiBona, Adlai R. Grayson
Publikováno v:
Molecular Cancer Therapeutics. 18:B014-B014
Introduction: NUT carcinoma (NC) is an aggressive subtype of squamous carcinoma whose growth is driven by the BRD4-NUT fusion oncoprotein. With a median survival of 6.7 months, NC is perhaps the most aggressive solid tumor in humans, and there exist
Autor:
Janine E. Elya, Christopher A. French, Artyom A. Alekseyenko, Hitoshi Shiota, Shelby A. Gorman, Kelly Becht, Mitzi I. Kuroda, Valentina Nardi, Olena Barbash, Pauline M. Chou, Kristina Danga
Nuclear protein in testis (NUT) carcinoma (NC) is a rare, distinctly aggressive subtype of squamous carcinoma defined by the presence of NUT-fusion oncogenes resulting from chromosomal translocation. In most cases, the NUT gene (NUTM1) is fused to br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db146bd7c5d0ca9f78a7653709d90cf8
https://europepmc.org/articles/PMC6279489/
https://europepmc.org/articles/PMC6279489/
Autor:
Valentina Nardi, Janine E. Elya, Kristina Danga, Hitoshi Shiota, Pauline M. Chou, Kelly Becht, Christopher A. French, Artyom A. Alekseyenko
Publikováno v:
Cancer Research. 78:2487-2487
INTRODUCTION. NUT Carcinoma (NC) is a rare, aggressive squamous carcinoma characterized by chromosome translocations involving rearrangement of the NUT gene (also known as NUTM1) on chromosome 15. While the BRD4-NUT fusion oncoprotein drives the majo
Autor:
Arindam Dhar, Jeanenne J. Nelson, Clement Ma, Christopher S. Lathan, Geoffrey I. Shapiro, Ryan Barrette, Nicole G. Chau, Stephen E. Sallan, Hasan Al-Sayegh, Madhumitha Sridharan, Robert I. Haddad, Valentina Nardi, Steven G. DuBois, Christopher A. French, Kristina Danga
Publikováno v:
Journal of Clinical Oncology. 36:6085-6085
6085Background: NUT midline carcinoma (NMC) is a rare subtype of squamous cancer defined by rearrangement of the NUT gene. Due to its rarity and under-diagnosis, there are no existing models to cla...